SG
Therapeutic Areas
Translumina Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Next-Gen Drug-Eluting Stents | Coronary Artery Disease | Development |
| Drug-Eluting Balloon Portfolio Expansion | Vascular Restenosis | Development/Commercial Expansion |
| Geographic Market Expansion | Coronary Artery Disease | Commercial |